About Us

Who We Are

VetCell Therapeutics USA is comprised of a team of passionate doctors, veterinarians, scientists and pet owners who are all focused on one thing…

Providing Relief to Sick Pets On a Cellular Level.

We started our mission in 2015 with the goal of extending the promise of cellular treatments to pets suffering from acute and chronic inflammatory diseases for which there are no cures. Today, we are in the clinical stage for multiple treatments and are determined to become the first cell therapy provider to obtain FDA approval for our allogenic mesenchymal stem cell products.

What We Do

We develop cell therapies for cats and dogs based on a proven, proprietary scientific platform. We’re focused on converting the vast lab-observed therapeutic benefits of multipoint stem cells into treatments that improve the quality of life for pets suffering from diseases for which there are no cures.

We’re teaming up with some of the most well-recognized veterinary schools and academic institutions in the world. Together, we’re collaborating on product development and conducting clinical trials to assess the impact our therapeutics have on treating various disease models. 

Key Team Members

THOMAS C.K. YUEN

THOMAS C.K. YUEN

Founder + Chairman of the Board

Thomas Yuen began his “America Dream” success story as a serial entrepreneur; founding several publicly traded companies such as AST Research Inc. and SRS Labs, Inc. Fueled by his own battle with chronic kidney disease (CKD) and with a successful five decades in the computer and electronics industry under his belt, Tom shifted his attention toward his passion for medical regenerative therapies.

Tom began researching stem cells in the 1980’s. Eventually, this research led Tom to embark on a journey toward the scientific expansion of stem cell research into therapeutic applications. In 2002, Tom purchased PrimeGen, a pioneer in the stem cell space and has since assembled a team of professional scientists to further PrimeGen’s understanding of stem cells and their various therapeutic properties. Through his work, Tom aims to advance the domain of stem cell research and improve the quality of life for people and animals suffering from chronic or debilitating diseases.

AWARDS & ACCOMPLISHMENTS

1974 | UC Irvine – B.S. Electrical Engineering w/ Honors
1986 | UC Irvine – Distinguished Alumnus Award
1987 | UC Irvine – Outstanding Engineering Alumni Award

1990 | UC Irvine – UC Irvine Medal
1991 | Beijing, China – Honorary Minzu University professor

2012 | TechAmerica – Lifetime Achievement Award
2014 | UC Irvine – Extraordinarius Award

UC Irvine Foundation Board of Trustees
Providence Speech & Hearing Center Board
UC Irvine Institute for Innovation Founding Board

MR. WAI SZETO

MR. WAI SZETO

Chief Operating Officer and Executive Vice President

Wai Szeto is an accomplished business development strategist with hands-on experience managing domestic, foreign and joint ventures. Szeto has been instrumental in developing global supply chains and manufacturing facilities for some of the largest companies in the world. Mr. Szeto is seasoned at developing and managing strategic international business deals that have brought billions of dollars in revenue for the companies he has worked for.

Prior to his role as COO at PrimeGen Global, Mr. Szeto was the general manager and vice chairman of Kingston China, and vice president, strategic business development at Kingston Technology. At Kingston, Mr. Szeto formed business alliances with major semiconductor companies, set up worldwide supply chain and manufacturing facilities, oversaw corporate mergers and grew major accounts worth hundreds of thousands of dollars annually. Prior to Kingston, Mr. Szeto served as vice president of global operations at AST Research, a Fortune 500 and, one of the world’s leading personal computer manufacturers at the time, where he managed engineering groups that created leading-edge personal computers, developed global manufacturing and supply chain networks, managed strategic supplier relationships and oversaw Asia Pacific marketing and sales. Mr. Szeto received a bachelor’s degree in electrical engineering from California Polytechnic State University, Pomona in 1971 and a master’s in computer science from USC in 1974.

DR. FARI IZADYAR DVM, PH.D.

DR. FARI IZADYAR DVM, PH.D.

Chief Veterinary Scientific Officer

Dr. Fari Izadyar is a veterinarian and well-established scientist in the field of reproductive biology and stem cell research. With over 25 years of experience as a large animal practitioner and scientist, Dr. Izadyar’s has worked with and presented his research studies to private vet clinics and research laboratories, in both the academic and biotech industry. In addition, Dr. Izadyar’s has published numerous papers featured in peer-reviewed journals, directed research programs, both nationally and internationally, and contributed to the development of innovative technique for regenerative stem cell medical application.

Doctorate in Veterinary Medicine
Ph.D. Reproductive & Stem Cell Biology

DR. CHAD MAKI DVM

DR. CHAD MAKI DVM

Chief Veterinary Medical Officer

 

Dr. Chad Maki is a published primary care practitioner with extensive international training in veterinary medicine and over 15 years of experience in stem cell research. He received a medal for outstanding research for a joint stem cell project at the University of Edinburgh and Roslin Institute in Scotland, and was awarded a competitive grant for externship at the Colorado State College of Veterinary Medicine. Dr. Maki remains active with clinical trials and continues to present his research to veterinarians and universities globally. He has extensive experience with the FDA application process and strong collaborations with world renowned veterinary universities and researchers. He has conducted numerous clinical trials for cell therapies in the veterinary field and is leading the effort for cellular therapy drug approvals for veterinary medicine in the United States. Dr. Maki is further developing cellular therapies for companion animals and aims to implement these for chronic degenerative, inflammatory, and immune-modulated diseases worldwide.

B.S. Biochemistry, UC Berkeley
BVM&S (DVM), The Royal Dick School of Veterinary Studies, University of Edinburgh

TOM RAMOS MS, MBA

TOM RAMOS MS, MBA

Director of Marketing and Product Development

Mr. Ramos has a B.S. and M.S. in Immunology from Cal Poly Pomona as well as an executive M.B.A. from the University of California, Irvine. Mr. Ramos has over 20 years of practical laboratory experience in multiple areas of research that include stem cell characterizations, primary cell processing, T cell signal transduction, and dendritic cell biology. Mr. Ramos has technical expertise in flow cytometry, molecular biology, cell culture, histology, in-vivo studies, and immune-assays. Mr. Ramos has technical knowledge in a variety of science disciplines including neuroscience, physiology, immunology, virology, and hematology. In his previous lab, Mr. Ramos built a primary cell product business, directed all the technical efforts, and conducted sales with customer support. Mr. Ramos has co-authored many publications and has presented at scientific meetings.

B.S. and M.S. Immunology, Cal Poly Pomona
Executive M.B.A., University of California, Irvine

Copyright © 2020 PrimeGen US

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. VetCell Therapeutics USA makes no representation and assumes no responsibility for the accuracy of information contained on or available through this web site, and such information is subject to change without notice.

You are encouraged to confirm any information obtained from or through this web site with other sources, and review all information regarding any medical condition or treatment with your physician.

NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH ANY WEB SITE.